While GLP-1 medications are not FDA-approved specifically for polycystic ovary syndrome (PCOS), they may be helpful in managing some symptoms, especially insulin resistance and weight gain
Abstract This review focuses on the anabolic effects of IGF-1 signaling on the skeleton, emphasizing the requirement for IGF-1 signaling in normal bone formation and remodeling
The future of beauty is inside out, and glutathione is at the forefront
Check with your pharmacy or insurance to confirm coverage before starting treatment
A 2025 systematic review by Vasireddi and colleagues in HSS Journal screened 544 published papers and identified 36 meeting inclusion criteria 35 preclinical studies and only one human study: an uncontrolled, unblinded, retrospective case series of 12 patients receiving intra-articular BPC-157 for chronic knee pain, in which 7 of 12 (58%) reported self-described relief lasting more than 6 months, with no dose, effect size, or systematically collected adverse events published
Providers will need to balance appropriate prescribing with growing consumer interest